BB
ABBV icon

Bell Bank’s AbbVie ABBV Stock Holding History

Bell Bank’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6M Buy
53,948
+297
+0.6% +$63.9K 0.52% 26
2026
Q1 		$11.7M Buy
53,651
+736
+1% +$163K 0.49% 29
2025
Q4 		$12.1M Sell
52,915
-7,333
-12% -$1.67M 0.52% 25
2025
Q3 		$13.9M Sell
60,248
-10,943
-15% -$2.23M 0.6% 20
2025
Q2 		$13.2M Sell
71,191
-2,579
-3% -$479K 0.62% 20
2025
Q1 		$15.5M Buy
73,770
+620
+0.8% +$121K 0.83% 16
2024
Q4 		$13M Buy
73,150
+6,333
+9% +$1.16M 0.97% 14
2024
Q3 		$13.2M Sell
66,817
-4,705
-7% -$878K 1.56% 12
2024
Q2 		$12.3M Buy
71,522
+360
+0.5% +$59.6K 1.03% 11
2024
Q1 		$13M Buy
71,162
+404
+0.6% +$69.6K 1.11% 9
2023
Q4 		$11M Buy
70,758
+990
+1% +$144K 1.06% 10
2023
Q3 		$10.4M Sell
69,768
-347
-0.5% -$50.9K 1.14% 9
2023
Q2 		$9.45M Sell
70,115
-483
-0.7% -$70.8K 1% 13
2023
Q1 		$11.3M Sell
70,598
-1,879
-3% -$287K 1.19% 10
2022
Q4 		$11.7M Sell
72,477
-765
-1% -$117K 1.36% 12
2022
Q3 		$9.83M Buy
73,242
+7,666
+12% +$1.1M 1.26% 11
2022
Q2 		$10M Buy
65,576
+3,924
+6% +$600K 1.2% 12
2022
Q1 		$9.99M Buy
61,652
+5,272
+9% +$766K 1.12% 13
2021
Q4 		$7.63M Buy
56,380
+7,609
+16% +$899K 0.87% 16
2021
Q3 		$5.26M Buy
48,771
+2,559
+6% +$292K 0.66% 19
2021
Q2 		$5.21M Buy
46,212
+2,755
+6% +$310K 0.69% 20
2021
Q1 		$4.7M Buy
43,457
+3,412
+9% +$365K 0.68% 17
2020
Q4 		$4.29M Buy
40,045
+2,006
+5% +$193K 0.66% 14
2020
Q3 		$3.33M Sell
38,039
-1,570
-4% -$148K 0.59% 18
2020
Q2 		$3.89M Sell
39,609
-18,128
-31% -$1.6M 0.72% 11
2020
Q1 		$4.4M Sell
57,737
-142
-0.2% -$12.1K 0.96% 12
2019
Q4 		$5.13M Sell
57,879
-907
-2% -$75.3K 0.93% 13
2019
Q3 		$4.45M Buy
58,786
+1,957
+3% +$134K 0.84% 13
2019
Q2 		$4.13M Buy
56,829
+3,871
+7% +$304K 0.93% 10
2019
Q1 		$4.27M Buy
52,958
+44,704
+542% +$3.66M 1.14% 9
2018
Q4 		$761K Hold
8,254
– – 0.23% 68
2018
Q3 		$781K Sell
8,254
-5,689
-41% -$539K 0.24% 72
2018
Q2 		$1.29M Sell
13,943
-1
-0% -$98 0.4% 51
2018
Q1 		$1.32M Hold
13,944
– – 0.42% 53
2017
Q4 		$1.35M Buy
13,944
+22
+0.2% +$2.07K 0.38% 55
2017
Q3 		$1.24M Sell
13,922
-101
-0.7% -$7.69K 0.36% 54
2017
Q2 		$1.02M Hold
14,023
– – 0.36% 55
2017
Q1 		$914K Hold
14,023
– – 0.34% 55
2016
Q4 		$878K Sell
14,023
-169
-1% -$10.3K 0.34% 53
2016
Q3 		$895K Buy
14,192
+331
+2% +$21.4K 0.56% 50
2016
Q2 		$858K Hold
13,861
– – 0.49% 52
2016
Q1 		$792K Hold
13,861
– – 0.52% 51
2015
Q4 		$821K Sell
13,861
-38
-0.3% -$2.19K 0.59% 52
2015
Q3 		$756K Sell
13,899
-22
-0.2% -$1.43K 0.6% 79
2015
Q2 		$935K Sell
13,921
-572
-4% -$37.3K 0.69% 51
2015
Q1 		$848K Buy
14,493
+221
+2% +$13.4K 0.6% 72
2014
Q4 		$934K Sell
14,272
-204
-1% -$12.9K 0.64% 61
2014
Q3 		$836K Buy
14,476
+107
+0.7% +$5.94K 0.6% 67
2014
Q2 		$811K Sell
14,369
-123
-0.8% -$6.45K 0.57% 72
2014
Q1 		$745K Buy
14,492
+391
+3% +$19.8K 0.5% 89
2013
Q4 		$745K Sell
14,101
-190
-1% -$9.34K 0.39% 118
2013
Q3 		$639K Sell
14,291
-70
-0.5% -$3.1K 0.22% 167
2013
Q2 		$594K Buy
+14,361
New +$628K 0.21% 168

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Bell Bank's ABBV Position: Q2 2026 in Review

Bell Bank increased its AbbVie (ABBV) stake by 0.55% in Q2 2026, buying an estimated $63.9K and bringing the position to 53,948 shares worth $13.6M. The position accounts for 0.52% of the portfolio, ranked #26.

Bell Bank first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.5M in Q1 2025. 812 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bell Bank held 53,948 shares of AbbVie worth $13.6M as of Q2 2026.
  • Bell Bank bought 297 AbbVie shares in Q2 2026, an estimated $63.9K.
  • AbbVie made up 0.52% of Bell Bank's portfolio in Q2 2026, its #26 holding.
  • Bell Bank first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Bell Bank's AbbVie position peaked at $15.5M in Q1 2025.
  • 812 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bell Bank's 13F filing for Q2 2026, filed 16 Jul 2026.